Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Boston Medical Group vs Prime Health

Boston Medical Group
Graded #279

Higher grade

vs+2.5
Prime Health
Graded #344

Lower grade

The verdict

Boston Medical Group takes it — 61.9/100 to 59.4/100.

Boston Medical Group grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Boston Medical Group is an established medical group running a 12-week compounded GLP-1 weight-loss programme.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueBoston Medical Group +12
54
42
Dose & formulationPrime Health +12
52
64
Clinical oversightBoston Medical Group +15
89
74
Labs & monitoringPrime Health +12
53
65
FulfillmentPrime Health +4
65
69
Contract termsBoston Medical Group +14
55
41
Boston Medical Group · left barPrime Health · right bar

The numbers

MetricBoston Medical GroupPrime Health
WeighScore61.9/10059.4/100
GradeCC
Scorecard rank#279#344
Semaglutide$199/mo (starting strength, rising with dose, compounded)$299/mo (compounded)
TirzepatideNot disclosed$399/mo (compounded)
Coverage7 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Boston Medical Group

Graded #279 · C

Strengths

  • An established medical group with a defined 12-week programme rather than an open-ended subscription
  • The price range and the 12-week total are both published, once you reach the costs page
  • Semaglutide is prescribed and dispensed under a compounded pathway with clinician oversight

Where it loses points

  • The published rate is a range by dose strength, $199 to $299, so the figure quoted is the floor rather than what a titrated patient pays
  • The 12-week programme totals $699 including a telemedicine platform fee that is never itemised — about $233/mo all-in, not $199
  • The weight-loss landing page carries no price at all; the numbers are two pages deeper, in the FAQ and the costs page
  • Semaglutide and tirzepatide are not priced separately — one range covers the whole programme
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products
Prime Health

Graded #344 · C

Strengths

  • LegitScript-certified platform
  • Flat pricing that does not rise as dosage increases
  • Bundle includes medication, labs, shipping, and unlimited clinician access
  • Money-back guarantee of at least 10% body-weight loss in 4 months
  • Fast 24-hour prescription review and 5-7 day delivery

Where it loses points

  • Compounded medications only; no FDA-approved brand options listed
  • Not available in Louisiana
  • Care delivered through third-party clinician groups, not in-house
  • Named compounding pharmacy not disclosed
  • No insurance accepted

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard